AX AI's in-house developed de novo suite coupled with AX AI's pose and affinity prediction software allows us to design new, patentable compounds for your selected target.
If you have fragments, hits or leads that you want to optimize then we can start with them in our molecule diversification module.
Newly designed compounds are designed with optimized ADME properties, minimal off-target and adverse events and ease of synthesis in mind.
